Nifty
:
24334.30
Sensex
:
78151.45
261.55 (1.09%)
964.58 (1.25%)
Nifty
Sensex
:
:
24334.30
78151.45
261.55 (1.09%)
964.58 (1.25%)

Sun Pharmaceutical Industries Ltd.

Pharmaceuticals & Drugs - Global

Rating :
70/99

BSE: 524715 | NSE: SUNPHARMA

NSE BSE
1932.60
17-Jul-2026
  • Open
  • High
  • Low
  • Previous Close
  •  1948.7
  •  1952.6
  •  1922.5
  •  1950.10
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  2475664
  •  4795722023.2
  •  1962.7
  •  1548

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 4,63,815.44
  • 40.76
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 4,56,293.97
  • 0.83%
  • 5.60

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 54.48%
  • 2.05%
  • 5.48%
  • FII
  • DII
  • Others
  • 14.54%
  • 19.97%
  • 3.48%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.44
  • 8.63
  • 6.43

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.47
  • 10.79
  • 5.28

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.19
  • 28.52
  • 6.26

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 38.33
  • 38.11
  • 38.03

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 4.19
  • 5.02
  • 5.56

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 19.63
  • 21.90
  • 23.74

Earnings Forecasts:

(Updated: 11-07-2026)
Description
2026
2027
2028
2029
Adj EPS
67
-4
13.45
50.54
P/E Ratio
29.11
-487.53
144.99
38.59
Revenue
33.98
28.76
24.69
58251.2
EBITDA
65100.4
76891.1
84113.6
17114.1
Net Income
18821.9
23517.8
27005.5
12153.3
ROA
13153.6
16037.4
18583.9
12.64
P/B Ratio
-0.05
-0.05
-0.06
5.83
ROE
4.86
4.3
3.8
15.67
FCFF
14.85
16.02
16.46
7302.74
FCFF Yield
11074.2
12111.6
16716.8
1.73
Net Debt
2.63
2.87
3.97
-29171.6
BVPS
-37847.2
-37994
-32337
334.55

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Net Sales
14,611.79
12,958.84
12.76%
15,520.54
13,675.46
13.49%
14,478.31
13,291.39
8.93%
13,851.40
12,652.75
9.47%
Expenses
10,657.59
9,533.99
11.79%
10,725.97
9,666.44
10.96%
10,381.73
9,480.52
9.51%
9,778.78
9,045.13
8.11%
EBITDA
3,954.20
3,424.85
15.46%
4,794.57
4,009.02
19.59%
4,096.58
3,810.87
7.50%
4,072.62
3,607.62
12.89%
EBIDTM
27.06%
26.43%
30.89%
29.32%
28.29%
28.67%
29.40%
28.51%
Other Income
458.50
904.11
-49.29%
732.76
465.62
57.37%
900.39
482.09
86.77%
693.50
532.55
30.22%
Interest
85.89
49.14
74.79%
78.36
51.51
52.13%
99.86
69.17
44.37%
74.80
61.54
21.55%
Depreciation
775.47
663.79
16.82%
732.33
630.56
16.14%
729.50
625.91
16.55%
700.55
655.13
6.93%
PBT
3,551.34
3,254.35
9.13%
4,227.16
3,476.40
21.60%
4,167.61
3,597.88
15.84%
3,172.77
3,423.50
-7.32%
Tax
827.62
1,093.71
-24.33%
826.07
558.86
47.81%
1,030.52
567.21
81.68%
870.15
552.25
57.56%
PAT
2,723.72
2,160.64
26.06%
3,401.09
2,917.54
16.57%
3,137.09
3,030.67
3.51%
2,302.62
2,871.25
-19.80%
PATM
18.64%
16.67%
21.91%
21.33%
21.67%
22.80%
16.62%
22.69%
EPS
11.31
8.96
26.23%
14.04
12.10
16.03%
13.00
12.67
2.60%
9.50
11.82
-19.63%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Net Sales
-
58,462.04
52,578.44
48,496.85
43,885.68
38,654.49
33,498.14
32,837.50
29,065.91
26,415.54
31,308.14
Net Sales Growth
-
11.19%
8.42%
10.51%
13.53%
15.39%
2.01%
12.98%
10.03%
-15.63%
 
Cost Of Goods Sold
-
11,543.68
10,747.36
10,662.61
10,662.16
10,351.54
8,690.08
9,230.45
7,868.97
7,351.71
8,164.20
Gross Profit
-
46,918.36
41,831.08
37,834.24
33,223.52
28,302.95
24,808.06
23,607.05
21,196.94
19,063.83
23,143.94
GP Margin
-
80.25%
79.56%
78.01%
75.70%
73.22%
74.06%
71.89%
72.93%
72.17%
73.92%
Total Expenditure
-
41,970.82
37,492.28
35,747.77
32,298.12
28,772.68
25,030.42
25,863.35
22,792.27
20,880.73
21,625.92
Power & Fuel Cost
-
813.66
750.40
760.78
830.05
702.78
595.58
586.18
580.15
527.76
488.46
% Of Sales
-
1.39%
1.43%
1.57%
1.89%
1.82%
1.78%
1.79%
2.00%
2.00%
1.56%
Employee Cost
-
11,418.86
9,973.12
9,429.06
8,296.03
7,300.83
6,126.18
5,703.57
5,297.62
4,707.99
4,311.85
% Of Sales
-
19.53%
18.97%
19.44%
18.90%
18.89%
18.29%
17.37%
18.23%
17.82%
13.77%
Manufacturing Exp.
-
2,564.42
2,261.24
2,186.62
1,936.77
1,880.71
3,486.62
3,341.64
3,399.20
3,490.23
3,393.59
% Of Sales
-
4.39%
4.30%
4.51%
4.41%
4.87%
10.41%
10.18%
11.69%
13.21%
10.84%
General & Admin Exp.
-
6,082.90
5,646.06
5,252.93
4,256.12
3,270.55
2,224.76
2,431.10
2,033.01
2,112.01
1,834.14
% Of Sales
-
10.40%
10.74%
10.83%
9.70%
8.46%
6.64%
7.40%
6.99%
8.00%
5.86%
Selling & Distn. Exp.
-
7,748.24
6,576.86
5,780.26
5,226.24
4,096.33
3,103.96
3,654.48
2,621.13
1,864.55
2,520.64
% Of Sales
-
13.25%
12.51%
11.92%
11.91%
10.60%
9.27%
11.13%
9.02%
7.06%
8.05%
Miscellaneous Exp.
-
1,799.06
1,537.24
1,675.51
1,090.75
1,169.94
803.24
915.93
992.19
826.48
2,520.64
% Of Sales
-
3.08%
2.92%
3.45%
2.49%
3.03%
2.40%
2.79%
3.41%
3.13%
2.92%
EBITDA
-
16,491.22
15,086.16
12,749.08
11,587.56
9,881.81
8,467.72
6,974.15
6,273.64
5,534.81
9,682.22
EBITDA Margin
-
28.21%
28.69%
26.29%
26.40%
25.56%
25.28%
21.24%
21.58%
20.95%
30.93%
Other Income
-
3,211.90
2,150.57
1,628.24
693.75
1,437.42
859.17
651.59
1,059.44
912.08
1,030.20
Interest
-
338.91
231.36
238.47
172.00
127.35
141.43
302.73
555.25
517.57
399.80
Depreciation
-
2,937.85
2,575.39
2,556.64
2,529.43
2,143.74
2,079.95
2,052.78
1,753.25
1,499.84
1,264.75
PBT
-
16,426.36
14,429.98
11,582.21
9,579.88
9,048.14
7,105.51
5,270.23
5,024.58
4,429.48
9,047.87
Tax
-
3,554.36
2,772.03
1,439.45
847.59
1,075.50
514.69
822.80
600.88
911.04
1,211.57
Tax Rate
-
23.51%
20.16%
12.98%
9.01%
24.00%
18.39%
16.42%
15.77%
26.19%
13.39%
PAT
-
11,535.29
10,944.39
9,614.79
8,521.48
3,289.27
2,916.15
3,779.76
2,666.88
2,121.14
6,954.44
PAT before Minority Interest
-
11,564.52
10,980.10
9,648.44
8,560.84
3,405.82
2,284.68
4,186.79
3,209.32
2,567.94
7,836.30
Minority Interest
-
-29.23
-35.71
-33.65
-39.36
-116.55
631.47
-407.03
-542.44
-446.80
-881.86
PAT Margin
-
19.73%
20.82%
19.83%
19.42%
8.51%
8.71%
11.51%
9.18%
8.03%
22.21%
PAT Growth
-
5.40%
13.83%
12.83%
159.07%
12.79%
-22.85%
41.73%
25.73%
-69.50%
 
EPS
-
48.08
45.61
40.07
35.52
13.71
12.15
15.75
11.12
8.84
28.99

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Shareholder's Funds
83,570.09
72,218.02
63,666.75
55,995.38
48,011.22
46,462.78
45,264.45
41,409.06
38,314.11
36,639.67
Share Capital
239.93
239.93
239.93
239.93
239.93
239.93
239.93
239.93
239.93
239.93
Total Reserves
83,330.16
71,978.09
63,426.82
55,755.45
47,771.29
46,222.85
45,024.52
41,169.13
38,074.18
36,397.10
Non-Current Liabilities
-1,763.02
-2,987.13
-2,714.34
-1,997.80
-1,316.37
-1,515.17
246.05
76.72
46.43
599.87
Secured Loans
0.00
0.00
0.00
0.00
0.00
251.25
257.49
109.47
217.69
185.59
Unsecured Loans
31.26
2.52
1.33
0.00
229.92
646.88
1,771.43
1,413.14
1,554.40
1,250.49
Long Term Provisions
525.07
473.80
413.89
342.91
369.07
327.12
511.00
430.39
404.46
1,211.11
Current Liabilities
22,622.04
18,194.21
16,983.77
19,906.38
17,208.45
16,145.63
15,706.43
17,339.62
19,864.32
17,887.02
Trade Payables
7,333.80
6,184.34
5,653.30
5,681.52
4,489.76
3,973.66
3,583.64
4,147.87
4,766.20
4,395.39
Other Current Liabilities
3,943.79
3,254.45
2,716.85
2,603.51
2,926.73
4,965.34
2,535.02
1,761.72
1,875.93
2,673.68
Short Term Borrowings
4,050.35
1,867.11
2,844.36
5,958.26
468.52
2,444.90
5,549.38
8,370.76
7,979.70
6,654.92
Short Term Provisions
7,294.10
6,888.31
5,769.26
5,663.09
9,323.44
4,761.73
4,038.39
3,059.27
5,242.49
4,163.03
Total Liabilities
1,04,738.76
87,693.03
81,395.37
77,224.05
66,958.19
64,110.29
65,077.17
62,138.94
62,109.02
58,917.42
Net Block
32,822.27
22,586.28
23,248.15
24,065.44
22,665.16
21,552.98
22,846.91
21,836.54
18,852.65
17,675.17
Gross Block
60,321.41
45,949.61
44,320.48
43,099.95
38,707.36
35,578.99
35,115.97
31,687.04
26,948.80
24,466.42
Accumulated Depreciation
27,499.14
23,363.33
21,072.33
19,034.51
16,042.20
14,026.01
12,269.06
9,850.50
8,096.15
6,791.25
Non Current Assets
40,847.57
35,068.56
37,921.02
37,341.33
32,093.59
33,668.21
33,423.01
31,069.75
30,473.12
25,963.77
Capital Work in Progress
3,051.73
6,643.96
5,353.88
4,973.16
1,286.80
1,566.83
1,220.34
1,411.15
2,465.16
2,801.38
Non Current Investment
3,789.07
4,697.70
6,441.23
5,451.73
5,214.65
6,482.39
5,245.75
3,951.81
3,052.25
961.00
Long Term Loans & Adv.
1,132.77
1,016.49
2,784.59
2,757.87
2,880.86
4,061.34
4,104.39
3,848.41
6,052.97
3,844.04
Other Non Current Assets
51.73
124.13
93.17
93.13
46.12
4.67
5.62
21.84
50.09
682.18
Current Assets
63,860.29
52,594.06
43,433.11
39,861.94
34,864.60
30,442.08
31,654.16
31,069.19
31,635.90
32,947.06
Current Investments
20,933.45
13,656.10
8,584.54
9,372.61
7,633.94
3,130.06
4,897.36
3,950.72
4,090.62
230.88
Inventories
11,492.93
10,243.33
9,868.29
10,513.05
8,925.13
8,997.02
7,874.99
7,885.98
6,880.69
6,832.81
Sundry Debtors
15,509.67
13,046.11
11,249.37
11,438.51
10,484.59
9,061.40
9,421.24
8,884.20
7,815.28
7,202.61
Cash & Bank
11,603.08
11,331.62
10,520.68
5,770.29
5,033.35
6,445.51
6,487.55
7,275.60
9,929.38
15,140.84
Other Current Assets
4,321.16
624.54
755.99
745.91
2,787.59
2,808.09
2,973.02
3,072.69
2,919.93
3,539.92
Short Term Loans & Adv.
3,606.01
3,692.36
2,454.24
2,021.57
2,012.58
1,488.98
1,431.54
1,806.39
2,028.62
2,828.26
Net Current Assets
41,238.25
34,399.85
26,449.34
19,955.56
17,656.15
14,296.45
15,947.73
13,729.57
11,771.58
15,060.04
Total Assets
1,04,707.86
87,662.62
81,354.13
77,203.27
66,958.19
64,110.29
65,077.17
62,138.94
62,109.02
58,910.83

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Cash From Operating Activity
12,419.18
14,072.09
12,134.98
4,959.33
8,984.54
6,170.37
6,554.77
2,196.45
3,907.15
7,082.21
PBT
15,118.88
13,752.13
11,087.89
9,408.43
4,481.32
2,799.37
5,009.59
3,810.20
3,478.98
9,047.87
Adjustment
882.03
1,120.36
1,554.40
2,722.56
1,974.95
1,809.85
1,992.54
1,968.66
1,382.22
500.67
Changes in Working Capital
-1,267.79
-323.56
1,062.13
-5,661.82
1,559.05
2,564.09
898.55
-2,696.00
-212.31
-409.21
Cash after chg. in Working capital
14,733.12
14,548.93
13,704.42
6,469.17
8,015.32
7,173.31
7,900.68
3,082.86
4,648.89
9,139.33
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-2,313.94
-476.84
-1,569.44
-1,509.84
969.22
-1,002.94
-1,345.91
-886.41
-741.74
-2,057.12
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-11,344.05
-5,306.16
-690.20
-7,943.68
-5,724.74
536.22
-2,588.84
-681.25
-3,370.81
-4,221.60
Net Fixed Assets
-1,295.94
-1,266.19
-420.26
-573.97
-1,120.95
-8,061.35
-737.44
-543.38
-1,471.92
-1,217.15
Net Investments
-541.45
19.86
183.27
2,935.63
-11.67
1,824.52
542.39
451.15
978.04
3,038.39
Others
-9,506.66
-4,059.83
-453.21
-10,305.34
-4,592.12
6,773.05
-2,393.79
-589.02
-2,876.93
-6,042.84
Cash from Financing Activity
-2,512.55
-7,905.82
-6,710.16
2,376.07
-5,193.46
-5,980.48
-5,715.14
-2,730.52
-1,539.26
-2,285.39
Net Cash Inflow / Outflow
-1,437.42
860.11
4,734.62
-608.28
-1,933.66
726.11
-1,749.21
-1,215.32
-1,002.92
575.22
Opening Cash & Equivalents
10,268.77
9,285.65
4,623.73
4,508.25
6,273.03
5,676.61
7,062.30
7,906.45
8,642.36
8,031.69
Closing Cash & Equivalent
9,770.51
10,268.77
9,285.65
4,623.73
4,508.25
6,273.03
5,676.61
7,062.30
7,906.45
8,642.36

Financial Ratios

Consolidated /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Book Value (Rs.)
348.31
301.00
265.36
233.38
200.11
193.65
188.66
172.59
159.69
152.70
ROA
12.02%
12.99%
12.17%
11.88%
5.20%
3.54%
6.58%
5.17%
4.24%
0.00%
ROE
14.85%
16.16%
16.13%
16.46%
7.21%
4.98%
9.66%
8.05%
6.85%
0.00%
ROCE
19.11%
19.89%
17.60%
17.24%
9.28%
5.68%
10.07%
8.68%
8.40%
0.00%
Fixed Asset Turnover
1.10
1.16
1.11
1.07
1.81
1.74
1.78
1.92
1.99
1.29
Receivable days
89.14
84.33
85.38
91.17
53.09
54.88
56.22
54.10
53.53
83.25
Inventory Days
67.85
69.81
76.70
80.83
48.68
50.10
48.40
47.84
48.88
78.98
Payable days
213.72
201.01
194.01
174.10
149.21
158.71
152.86
77.81
90.19
85.47
Cash Conversion Cycle
-56.72
-46.88
-31.93
-2.10
-47.44
-53.73
-48.24
24.13
12.23
76.75
Total Debt/Equity
0.05
0.03
0.04
0.11
0.02
0.08
0.18
0.25
0.27
0.27
Interest Cover
45.61
60.44
47.50
55.70
36.19
20.79
17.55
7.86
7.72
23.63

Annual Reports:

FY 2026
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017

News Update:


  • Sun Pharma gets nod to manufacture, market generic semaglutide in South Africa
    15th Jul 2026, 10:43 AM

    The company has secured approval from the South African Health Products Regulatory Authority

    Read More
  • Sun Pharma to acquire Innovcare Lifesciences
    22nd Jun 2026, 11:20 AM

    The deal is worth around Rs 271.2 crore

    Read More
  • Sun Pharma Inds. - Quarterly Results
    23rd May 2026, 00:00 AM

    Read More
  • Sun Pharma reports 26% rise in Q4 consolidated net profit
    22nd May 2026, 16:22 PM

    The total consolidated income of the company has increased by 11.04% at Rs 15,070.29 crore for Q4FY26

    Read More
  • Sun Pharmaceutical to acquire all outstanding shares of Organon
    27th Apr 2026, 10:10 AM

    The proposed acquisition of Organon is aligned with Sun Pharma’s strategy of growing its Innovative Medicines business

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.